• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于循环细胞捕获的脱细胞人心脏瓣膜与CD133抗体的偶联

CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture.

作者信息

Vossler John D, Min Ju Young, Williams J Koudy, Goldstein Steven, Hamlin James, Lee Sang Jin, Yoo James J, Atala Anthony

机构信息

Wake Forest Institute for Regenerative Medicine and, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Department of General Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.

出版信息

Biomed Mater. 2015 Sep 3;10(5):055001. doi: 10.1088/1748-6041/10/5/055001.

DOI:10.1088/1748-6041/10/5/055001
PMID:26333364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5104175/
Abstract

The long term efficacy of tissue based heart valve grafts may be limited by progressive degeneration characterized by immune mediated inflammation and calcification. To avoid this degeneration, decellularized heart valves with functionalized surfaces capable of rapid in vivo endothelialization have been developed. The aim of this study is to examine the capacity of CD133 antibody-conjugated valve tissue to capture circulating endothelial progenitor cells (EPCs). Decellularized human pulmonary valve tissue was conjugated with CD133 antibody at varying concentrations and exposed to CD133 expressing NTERA-2 cl.D1 (NT2) cells in a microflow chamber. The amount of CD133 antibody conjugated on the valve tissue surface and the number of NT2 cells captured in the presence of shear stress was measured. Both the amount of CD133 antibody conjugated to the valve leaflet surface and the number of adherent NT2 cells increased as the concentration of CD133 antibody present in the surface immobilization procedure increased. The data presented in this study support the hypothesis that the rate of CD133(+) cell adhesion in the presence of shear stress to decellularized heart valve tissue functionalized by CD133 antibody conjugation increases as the quantity of CD133 antibody conjugated to the tissue surface increases.

摘要

基于组织的心脏瓣膜移植物的长期疗效可能会受到以免疫介导的炎症和钙化为特征的进行性退变的限制。为避免这种退变,已开发出具有能够在体内快速内皮化的功能化表面的去细胞心脏瓣膜。本研究的目的是检测与CD133抗体偶联的瓣膜组织捕获循环内皮祖细胞(EPC)的能力。将去细胞化的人肺动脉瓣膜组织与不同浓度的CD133抗体偶联,并在微流控腔室中暴露于表达CD133的NTERA-2 cl.D1(NT2)细胞。测量瓣膜组织表面偶联的CD133抗体的量以及在剪切应力存在下捕获的NT2细胞的数量。随着表面固定过程中存在的CD133抗体浓度增加,偶联到瓣膜小叶表面的CD133抗体的量和贴壁NT2细胞的数量均增加。本研究中呈现的数据支持这样的假设,即随着偶联到组织表面的CD133抗体数量增加,在剪切应力存在下CD133(+)细胞与通过CD133抗体偶联功能化的去细胞心脏瓣膜组织的粘附速率增加。

相似文献

1
CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture.用于循环细胞捕获的脱细胞人心脏瓣膜与CD133抗体的偶联
Biomed Mater. 2015 Sep 3;10(5):055001. doi: 10.1088/1748-6041/10/5/055001.
2
Characterization of CD133 Antibody-Directed Recellularized Heart Valves.
J Cardiovasc Transl Res. 2015 Oct;8(7):411-20. doi: 10.1007/s12265-015-9651-3. Epub 2015 Sep 4.
3
Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis.羟基丁基壳聚糖聚合物介导的金属支架CD133抗体涂层在猪动脉粥样硬化模型中减少再狭窄
J Cardiovasc Pharmacol Ther. 2015 May;20(3):322-9. doi: 10.1177/1074248414558518. Epub 2014 Nov 19.
4
Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization.固定在支架表面的抗CD133抗体可增强内皮化。
Biomed Res Int. 2014;2014:902782. doi: 10.1155/2014/902782. Epub 2014 Mar 10.
5
Two novel monoclonal antibodies against human CD133-2: distinct epitopes and agonist activity to enhance growth of CD133 expression cells in vitro.两种新型抗人CD133-2单克隆抗体:不同表位及在体外增强CD133表达细胞生长的激动剂活性
Hybridoma (Larchmt). 2010 Jun;29(3):241-9. doi: 10.1089/hyb.2009.0113.
6
Successful matrix guided tissue regeneration of decellularized pulmonary heart valve allografts in elderly sheep.成功实现去细胞化肺动脉瓣同种异体移植物的基质引导组织再生。
Biomaterials. 2015 Jun;52:221-8. doi: 10.1016/j.biomaterials.2015.02.023. Epub 2015 Feb 27.
7
First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.猪模型中抗人 CD133 抗体涂层冠状动脉支架的首次体外和体内研究结果。
Clin Res Cardiol. 2013 Jun;102(6):413-25. doi: 10.1007/s00392-013-0547-4. Epub 2013 Feb 10.
8
[The CD133 polyclonal antibody generation and cancer stem cells identification].[CD133多克隆抗体的产生及癌症干细胞的鉴定]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 May;42(3):422-6.
9
Synthetic ePTFE grafts coated with an anti-CD133 antibody-functionalized heparin/collagen multilayer with rapid in vivo endothelialization properties.合成 ePTFE 移植物涂覆有抗 CD133 抗体功能化肝素/胶原多层膜,具有快速体内内皮化特性。
ACS Appl Mater Interfaces. 2013 Aug 14;5(15):7360-9. doi: 10.1021/am401706w. Epub 2013 Jul 29.
10
Anti-human CD133 monoclonal antibody that could inhibit the proliferation of colorectal cancer cells.可抑制结肠癌细胞增殖的抗人CD133单克隆抗体。
Hybridoma (Larchmt). 2010 Aug;29(4):305-10. doi: 10.1089/hyb.2010.0019.

引用本文的文献

1
Effect of intracellular uptake of nanoparticle-encapsulated trehalose on the hemocompatibility of allogeneic valves in the VS83 vitrification protocol.纳米颗粒包裹海藻糖的细胞内摄取对VS83玻璃化方案中同种异体瓣膜血液相容性的影响。
Nanobiomedicine (Rij). 2020 Dec 29;7:1849543520983173. doi: 10.1177/1849543520983173. eCollection 2020 Jan-Dec.

本文引用的文献

1
Immobilization of Fab' fragments onto substrate surfaces: A survey of methods and applications.Fab' 片段在基质表面的固定化:方法与应用综述。
Biosens Bioelectron. 2015 Aug 15;70:167-80. doi: 10.1016/j.bios.2015.03.032. Epub 2015 Mar 17.
2
Engineering patient-specific valves using stem cells generated from skin biopsy specimens.利用从皮肤活检标本中生成的干细胞来工程化患者特异性瓣膜。
Ann Thorac Surg. 2014 Sep;98(3):947-54. doi: 10.1016/j.athoracsur.2014.04.075. Epub 2014 Jul 16.
3
Magnetically guided recellularization of decellularized stented porcine pericardium-derived aortic valve for TAVI.用于经导管主动脉瓣置换术(TAVI)的去细胞带支架猪心包来源主动脉瓣的磁导向再细胞化
ASAIO J. 2014 Sep-Oct;60(5):582-6. doi: 10.1097/MAT.0000000000000110.
4
Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation.经过长期临床前评估,脱细胞异体心脏瓣膜显示出自我再生潜力。
PLoS One. 2014 Jun 18;9(6):e99593. doi: 10.1371/journal.pone.0099593. eCollection 2014.
5
The degeneration of biological cardiovascular prostheses under pro-calcific metabolic conditions in a small animal model.生物心血管假体在小动物模型促钙化代谢条件下的退化。
Biomaterials. 2014 Aug;35(26):7416-28. doi: 10.1016/j.biomaterials.2014.05.034. Epub 2014 Jun 7.
6
In vitro generation of atrioventricular heart valve neoscaffolds.体外生成房室心脏瓣膜新支架。
Artif Organs. 2014 Jul;38(7):E118-28. doi: 10.1111/aor.12321. Epub 2014 May 20.
7
Decellularized matrices for cardiovascular tissue engineering.用于心血管组织工程的脱细胞基质
Am J Stem Cells. 2014 Mar 13;3(1):1-20. eCollection 2014.
8
Valvular heart disease: classic teaching and emerging paradigms.瓣膜性心脏病:经典教学与新兴范式。
Am J Med. 2013 Dec;126(12):1035-42. doi: 10.1016/j.amjmed.2013.05.022. Epub 2013 Oct 11.
9
Evaluation of a novel tetra-functional branched poly(ethylene glycol) crosslinker for manufacture of crosslinked, decellularized, porcine aortic valve leaflets.评价一种新型四官能化支化聚乙二醇交联剂用于制造交联脱细胞猪主动脉瓣叶。
J Biomed Mater Res B Appl Biomater. 2014 Feb;102(2):322-36. doi: 10.1002/jbm.b.33010. Epub 2013 Sep 20.
10
Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization.心脏瓣膜组织工程:去细胞猪主动脉瓣的聚乙二醇化作为体外再细胞化的支架。
Biomed Eng Online. 2013 Sep 5;12:87. doi: 10.1186/1475-925X-12-87.